Full Breakdown
Susan E. Leeman: A Pioneer in Neuroendocrinology
2/25/2026, 10:56:18 AM
Core Contributions to Neuroendocrinology
Susan E. Leeman, a prominent endocrinologist, passed away on January 20, 2026, at the age of 95 in New York City. Her groundbreaking work in isolating and defining two neuropeptides, Substance P and neurotensin, significantly advanced the field of neuroendocrinology. Leeman's research established neuroendocrinology as a distinct discipline, with lasting implications for understanding pain, inflammation, and brain-body signaling. Her discoveries opened new avenues for research, particularly in the context of chronic pain and immune modulation.
Academic Background and Career
Born on May 9, 1930, in Chicago, Leeman earned her B.A. from Goucher College in 1951, followed by an M.A. and Ph.D. from Radcliffe College in 1954 and 1958, respectively. Her doctoral thesis focused on neurohormonal stimulation of adrenocorticotropic hormone secretion. Leeman joined Harvard Medical School in 1958 and held positions at Brandeis University, the University of Massachusetts Medical School, and Boston University School of Medicine, where she served as a professor and later as director of the Neuropeptide Laboratory.
Key Discoveries and Research Impact
Leeman's research was characterized by meticulous methodology. She and her team successfully detected, sequenced, and synthesized neuropeptides, which are crucial for transmitting signals in the nervous system. Her work on Substance P, initially discovered in 1931 but not fully understood until her identification of its neuropeptide nature in 1970, has been linked to chronic pain syndromes and migraines. This connection underscores the public health significance of her research, particularly in efforts to treat chronic pain and reduce reliance on opioids.
Recognition and Legacy
Throughout her career, Leeman received numerous accolades, including election to the American Academy of Arts and Sciences in 1987 and the National Academy of Sciences in 1991. She was awarded the FASEB Excellence in Science Award in 1993 and recognized as an AAAS Fellow in 2007. Colleagues and students remembered her as a pioneering figure who demonstrated courage in expressing dissent and maintaining intellectual integrity in her work.
Criticism and Challenges
Despite her achievements, Leeman's career unfolded during a time of significant sexism in the sciences. Her ability to make major discoveries in such an environment highlights both her resilience and the broader challenges faced by women in scientific fields.
Official Statements and Responses
Boston University’s Pharmacology, Physiology & Biophysics faculty expressed sorrow at her passing, describing her work as "pioneering." Colleagues shared personal tributes, emphasizing her role as a mentor and her commitment to ethical research practices.
Verbatim Quotes
- “In an era of overt sexism in the sciences, she made two major discoveries, including identifying a neuropeptide later linked to chronic pain syndromes and migraines.” — Society for Neuroscience summary
- “her rare courage in expressing dissent clearly and without fear, her intellectual integrity, and her refusal to compromise her values will be always remembered.” — Valentina and Pietro, colleagues
Susan E. Leeman's contributions to neuroendocrinology and her legacy as a mentor and pioneer will continue to influence future generations of researchers in the field.
